Marcozzi, Alessio http://orcid.org/0000-0001-7477-3661
Jager, Myrthe
Elferink, Martin http://orcid.org/0000-0002-7940-7422
Straver, Roy http://orcid.org/0000-0002-8031-1735
van Ginkel, Joost H.
Peltenburg, Boris
Chen, Li-Ting http://orcid.org/0000-0001-7956-5116
Renkens, Ivo
van Kuik, Joyce
Terhaard, Chris
de Bree, Remco
Devriese, Lot A.
Willems, Stefan M.
Kloosterman, Wigard P.
de Ridder, Jeroen http://orcid.org/0000-0002-0828-3477
Funding for this research was provided by:
This project was supported by the Oncode Clinical Proof of Concept fund
Article History
Received: 31 May 2021
Accepted: 9 November 2021
First Online: 9 December 2021
Change Date: 7 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41525-023-00356-x
Competing interests
: The authors declare the following financial competing interest: A.M., R.S., W.P.K., and J.d.R. filed patents and A.M., W.P.K., and J.d.R. founded a company (Cyclomics) based on CyclomicsSeq. The remaining authors declare no competing interests.